An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma

• Francesca Reggiani,
• Elisabetta Sauta,
• Federica Torricelli,
• Eleonora Zanetti,
• Elena Tagliavini,
• Giacomo Santandrea,
• Giulia Gobbi,
• Giovanna Damia,
• Riccardo Bellazzi,
• Davide Ambrosetti,
• Alessia Ciarrocchi,
• Valentina Sancisi

Affiliations

Francesca Reggiani

Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia

Elisabetta Sauta

Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia

Federica Torricelli

Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia

Eleonora Zanetti

Pathology Unit, Azienda USL-IRCCS di Reggio Emilia

Elena Tagliavini

Pathology Unit, Azienda USL-IRCCS di Reggio Emilia

Giacomo Santandrea

Pathology Unit, Azienda USL-IRCCS di Reggio Emilia

Giulia Gobbi

Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia

Giovanna Damia

Laboratory of Molecular Pharmacology, Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS

Riccardo Bellazzi

Department of Electrical, Computer and Biomedical Engineering, University of Pavia

Davide Ambrosetti

Department of Pharmacy and Biotechnology (FaBit), University of Bologna

Alessia Ciarrocchi

Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia

Valentina Sancisi

Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia